Global Clotting Factors Ⅷ Market Growth 2022-2028
- LP 4925873
- 71 Pages
- March 2022
- Pharmaceuticals
will have significant change from previous year. According to our (LP Information) latest study, the global Clotting Factors
market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Clotting Factors
market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Clotting Factors
market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Clotting Factors
market, reaching US$ million by the year 2028. As for the Europe Clotting Factors
landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Clotting Factors
players cover Lvshizi, Taibang Biological, Shanghai Laishi, and Hualan Biological, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Clotting Factors
market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Injection
Freeze-dried Injection
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hemophilia A
Bleeding Diseases
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Lvshizi
Taibang Biological
Shanghai Laishi
Hualan Biological
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Clotting Factors
Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Clotting Factors
by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Clotting Factors
by Country/Region, 2017, 2022 & 2028
2.2 Clotting Factors
Segment by Type
2.2.1 Injection
2.2.2 Freeze-dried Injection
2.3 Clotting Factors
Sales by Type
2.3.1 Global Clotting Factors
Sales Market Share by Type (2017-2022)
2.3.2 Global Clotting Factors
Revenue and Market Share by Type (2017-2022)
2.3.3 Global Clotting Factors
Sale Price by Type (2017-2022)
2.4 Clotting Factors
Segment by Application
2.4.1 Hemophilia A
2.4.2 Bleeding Diseases
2.5 Clotting Factors
Sales by Application
2.5.1 Global Clotting Factors
Sale Market Share by Application (2017-2022)
2.5.2 Global Clotting Factors
Revenue and Market Share by Application (2017-2022)
2.5.3 Global Clotting Factors
Sale Price by Application (2017-2022)
3 Global Clotting Factors
by Company
3.1 Global Clotting Factors
Breakdown Data by Company
3.1.1 Global Clotting Factors
Annual Sales by Company (2020-2022)
3.1.2 Global Clotting Factors
Sales Market Share by Company (2020-2022)
3.2 Global Clotting Factors
Annual Revenue by Company (2020-2022)
3.2.1 Global Clotting Factors
Revenue by Company (2020-2022)
3.2.2 Global Clotting Factors
Revenue Market Share by Company (2020-2022)
3.3 Global Clotting Factors
Sale Price by Company
3.4 Key Manufacturers Clotting Factors
Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Clotting Factors
Product Location Distribution
3.4.2 Players Clotting Factors
Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Clotting Factors
by Geographic Region
4.1 World Historic Clotting Factors
Market Size by Geographic Region (2017-2022)
4.1.1 Global Clotting Factors
Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Clotting Factors
Annual Revenue by Geographic Region
4.2 World Historic Clotting Factors
Market Size by Country/Region (2017-2022)
4.2.1 Global Clotting Factors
Annual Sales by Country/Region (2017-2022)
4.2.2 Global Clotting Factors
Annual Revenue by Country/Region
4.3 Americas Clotting Factors
Sales Growth
4.4 APAC Clotting Factors
Sales Growth
4.5 Europe Clotting Factors
Sales Growth
4.6 Middle East & Africa Clotting Factors
Sales Growth
5 Americas
5.1 Americas Clotting Factors
Sales by Country
5.1.1 Americas Clotting Factors
Sales by Country (2017-2022)
5.1.2 Americas Clotting Factors
Revenue by Country (2017-2022)
5.2 Americas Clotting Factors
Sales by Type
5.3 Americas Clotting Factors
Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Clotting Factors
Sales by Region
6.1.1 APAC Clotting Factors
Sales by Region (2017-2022)
6.1.2 APAC Clotting Factors
Revenue by Region (2017-2022)
6.2 APAC Clotting Factors
Sales by Type
6.3 APAC Clotting Factors
Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Clotting Factors
by Country
7.1.1 Europe Clotting Factors
Sales by Country (2017-2022)
7.1.2 Europe Clotting Factors
Revenue by Country (2017-2022)
7.2 Europe Clotting Factors
Sales by Type
7.3 Europe Clotting Factors
Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Clotting Factors
by Country
8.1.1 Middle East & Africa Clotting Factors
Sales by Country (2017-2022)
8.1.2 Middle East & Africa Clotting Factors
Revenue by Country (2017-2022)
8.2 Middle East & Africa Clotting Factors
Sales by Type
8.3 Middle East & Africa Clotting Factors
Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Clotting Factors
10.3 Manufacturing Process Analysis of Clotting Factors
10.4 Industry Chain Structure of Clotting Factors
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Clotting Factors
Distributors
11.3 Clotting Factors
Customer
12 World Forecast Review for Clotting Factors
by Geographic Region
12.1 Global Clotting Factors
Market Size Forecast by Region
12.1.1 Global Clotting Factors
Forecast by Region (2023-2028)
12.1.2 Global Clotting Factors
Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Clotting Factors
Forecast by Type
12.7 Global Clotting Factors
Forecast by Application
13 Key Players Analysis
13.1 Lvshizi
13.1.1 Lvshizi Company Information
13.1.2 Lvshizi Clotting Factors
Product Offered
13.1.3 Lvshizi Clotting Factors
Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Lvshizi Main Business Overview
13.1.5 Lvshizi Latest Developments
13.2 Taibang Biological
13.2.1 Taibang Biological Company Information
13.2.2 Taibang Biological Clotting Factors
Product Offered
13.2.3 Taibang Biological Clotting Factors
Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Taibang Biological Main Business Overview
13.2.5 Taibang Biological Latest Developments
13.3 Shanghai Laishi
13.3.1 Shanghai Laishi Company Information
13.3.2 Shanghai Laishi Clotting Factors
Product Offered
13.3.3 Shanghai Laishi Clotting Factors
Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Shanghai Laishi Main Business Overview
13.3.5 Shanghai Laishi Latest Developments
13.4 Hualan Biological
13.4.1 Hualan Biological Company Information
13.4.2 Hualan Biological Clotting Factors
Product Offered
13.4.3 Hualan Biological Clotting Factors
Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Hualan Biological Main Business Overview
13.4.5 Hualan Biological Latest Developments
14 Research Findings and Conclusion
Table 1. Clotting Factors
Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Clotting Factors
Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Freeze-dried Injection
Table 5. Global Clotting Factors
Sales by Type (2017-2022) & (K Units)
Table 6. Global Clotting Factors
Sales Market Share by Type (2017-2022)
Table 7. Global Clotting Factors
Revenue by Type (2017-2022) & ($ million)
Table 8. Global Clotting Factors
Revenue Market Share by Type (2017-2022)
Table 9. Global Clotting Factors
Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Clotting Factors
Sales by Application (2017-2022) & (K Units)
Table 11. Global Clotting Factors
Sales Market Share by Application (2017-2022)
Table 12. Global Clotting Factors
Revenue by Application (2017-2022)
Table 13. Global Clotting Factors
Revenue Market Share by Application (2017-2022)
Table 14. Global Clotting Factors
Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Clotting Factors
Sales by Company (2020-2022) & (K Units)
Table 16. Global Clotting Factors
Sales Market Share by Company (2020-2022)
Table 17. Global Clotting Factors
Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Clotting Factors
Revenue Market Share by Company (2020-2022)
Table 19. Global Clotting Factors
Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Clotting Factors
Producing Area Distribution and Sales Area
Table 21. Players Clotting Factors
Products Offered
Table 22. Clotting Factors
Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Clotting Factors
Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Clotting Factors
Sales Market Share Geographic Region (2017-2022)
Table 27. Global Clotting Factors
Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Clotting Factors
Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Clotting Factors
Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Clotting Factors
Sales Market Share by Country/Region (2017-2022)
Table 31. Global Clotting Factors
Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Clotting Factors
Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Clotting Factors
Sales by Country (2017-2022) & (K Units)
Table 34. Americas Clotting Factors
Sales Market Share by Country (2017-2022)
Table 35. Americas Clotting Factors
Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Clotting Factors
Revenue Market Share by Country (2017-2022)
Table 37. Americas Clotting Factors
Sales by Type (2017-2022) & (K Units)
Table 38. Americas Clotting Factors
Sales Market Share by Type (2017-2022)
Table 39. Americas Clotting Factors
Sales by Application (2017-2022) & (K Units)
Table 40. Americas Clotting Factors
Sales Market Share by Application (2017-2022)
Table 41. APAC Clotting Factors
Sales by Region (2017-2022) & (K Units)
Table 42. APAC Clotting Factors
Sales Market Share by Region (2017-2022)
Table 43. APAC Clotting Factors
Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Clotting Factors
Revenue Market Share by Region (2017-2022)
Table 45. APAC Clotting Factors
Sales by Type (2017-2022) & (K Units)
Table 46. APAC Clotting Factors
Sales Market Share by Type (2017-2022)
Table 47. APAC Clotting Factors
Sales by Application (2017-2022) & (K Units)
Table 48. APAC Clotting Factors
Sales Market Share by Application (2017-2022)
Table 49. Europe Clotting Factors
Sales by Country (2017-2022) & (K Units)
Table 50. Europe Clotting Factors
Sales Market Share by Country (2017-2022)
Table 51. Europe Clotting Factors
Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Clotting Factors
Revenue Market Share by Country (2017-2022)
Table 53. Europe Clotting Factors
Sales by Type (2017-2022) & (K Units)
Table 54. Europe Clotting Factors
Sales Market Share by Type (2017-2022)
Table 55. Europe Clotting Factors
Sales by Application (2017-2022) & (K Units)
Table 56. Europe Clotting Factors
Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Clotting Factors
Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Clotting Factors
Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Clotting Factors
Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Clotting Factors
Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Clotting Factors
Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Clotting Factors
Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Clotting Factors
Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Clotting Factors
Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Clotting Factors
Table 66. Key Market Challenges & Risks of Clotting Factors
Table 67. Key Industry Trends of Clotting Factors
Table 68. Clotting Factors
Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Clotting Factors
Distributors List
Table 71. Clotting Factors
Customer List
Table 72. Global Clotting Factors
Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Clotting Factors
Sales Market Forecast by Region
Table 74. Global Clotting Factors
Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Clotting Factors
Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Clotting Factors
Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Clotting Factors
Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Clotting Factors
Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Clotting Factors
Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Clotting Factors
Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Clotting Factors
Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Clotting Factors
Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Clotting Factors
Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Clotting Factors
Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Clotting Factors
Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Clotting Factors
Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Clotting Factors
Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Clotting Factors
Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Clotting Factors
Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Clotting Factors
Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Clotting Factors
Revenue Market Share Forecast by Application (2023-2028)
Table 92. Lvshizi Basic Information, Clotting Factors
Manufacturing Base, Sales Area and Its Competitors
Table 93. Lvshizi Clotting Factors
Product Offered
Table 94. Lvshizi Clotting Factors
Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Lvshizi Main Business
Table 96. Lvshizi Latest Developments
Table 97. Taibang Biological Basic Information, Clotting Factors
Manufacturing Base, Sales Area and Its Competitors
Table 98. Taibang Biological Clotting Factors
Product Offered
Table 99. Taibang Biological Clotting Factors
Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Taibang Biological Main Business
Table 101. Taibang Biological Latest Developments
Table 102. Shanghai Laishi Basic Information, Clotting Factors
Manufacturing Base, Sales Area and Its Competitors
Table 103. Shanghai Laishi Clotting Factors
Product Offered
Table 104. Shanghai Laishi Clotting Factors
Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Shanghai Laishi Main Business
Table 106. Shanghai Laishi Latest Developments
Table 107. Hualan Biological Basic Information, Clotting Factors
Manufacturing Base, Sales Area and Its Competitors
Table 108. Hualan Biological Clotting Factors
Product Offered
Table 109. Hualan Biological Clotting Factors
Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Hualan Biological Main Business
Table 111. Hualan Biological Latest Developments
List of Figures
Figure 1. Picture of Clotting Factors
Figure 2. Clotting Factors
Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Clotting Factors
Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Clotting Factors
Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Clotting Factors
Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Freeze-dried Injection
Figure 11. Global Clotting Factors
Sales Market Share by Type in 2021
Figure 12. Global Clotting Factors
Revenue Market Share by Type (2017-2022)
Figure 13. Clotting Factors
Consumed in Hemophilia A
Figure 14. Global Clotting Factors
Market: Hemophilia A (2017-2022) & (K Units)
Figure 15. Clotting Factors
Consumed in Bleeding Diseases
Figure 16. Global Clotting Factors
Market: Bleeding Diseases (2017-2022) & (K Units)
Figure 17. Global Clotting Factors
Sales Market Share by Application (2017-2022)
Figure 18. Global Clotting Factors
Revenue Market Share by Application in 2021
Figure 19. Clotting Factors
Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Clotting Factors
Revenue Market Share by Company in 2021
Figure 21. Global Clotting Factors
Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Clotting Factors
Revenue Market Share by Geographic Region in 2021
Figure 23. Global Clotting Factors
Sales Market Share by Region (2017-2022)
Figure 24. Global Clotting Factors
Revenue Market Share by Country/Region in 2021
Figure 25. Americas Clotting Factors
Sales 2017-2022 (K Units)
Figure 26. Americas Clotting Factors
Revenue 2017-2022 ($ Millions)
Figure 27. APAC Clotting Factors
Sales 2017-2022 (K Units)
Figure 28. APAC Clotting Factors
Revenue 2017-2022 ($ Millions)
Figure 29. Europe Clotting Factors
Sales 2017-2022 (K Units)
Figure 30. Europe Clotting Factors
Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Clotting Factors
Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Clotting Factors
Revenue 2017-2022 ($ Millions)
Figure 33. Americas Clotting Factors
Sales Market Share by Country in 2021
Figure 34. Americas Clotting Factors
Revenue Market Share by Country in 2021
Figure 35. United States Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Clotting Factors
Sales Market Share by Region in 2021
Figure 40. APAC Clotting Factors
Revenue Market Share by Regions in 2021
Figure 41. China Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Clotting Factors
Sales Market Share by Country in 2021
Figure 48. Europe Clotting Factors
Revenue Market Share by Country in 2021
Figure 49. Germany Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Clotting Factors
Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Clotting Factors
Revenue Market Share by Country in 2021
Figure 56. Egypt Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Clotting Factors
Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Clotting Factors
in 2021
Figure 62. Manufacturing Process Analysis of Clotting Factors
Figure 63. Industry Chain Structure of Clotting Factors
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
